Table 1.
Baseline characteristics of the study population
| Baseline characteristics | Group A (n = 35) | Group B (n = 35) | p value |
|---|---|---|---|
| Age (years) | 49 (25–74) | 48 (32–79) | 0.85 |
| Gender | |||
| Male | 29 (82.9%) | 28 (80%) | 0.76 |
| Female | 6 (17.1%) | 7 (20%) | |
| Etiology | |||
| Autoimmune hepatitis | 1 (3.03%) | 0 | |
| Hepatitis B | 1 (3.03%) | 2 (3.03%) | |
| Hepatitis C | 3 (9.09%) | 1 (3.03%) | 0.49 |
| NASH | 7 (18.18%) | 11 (30.3%) | |
| Alcohol | 23 (63.63%) | 20 (60.6%) | |
| Alcohol + hepatitis B | 0 | 1 (3.03%) | |
| Ascites | 31 (88.6%) | 33 (94.28%) | 0.39 |
| Duration (Months) | 3 (1–8) | 3 (1–6) | 0.43 |
| Grade of ascites | |||
| Grade 1 | 6 (17.1%) | 5 (14.3%) | |
| Grade 2 | 13 (37.1%) | 17 (48.6%) | 0.74 |
| Grade 3 | 12 (34.3%) | 11 (31.4%) | |
| Need for LVP | 12 (34.3%) | 11 (31.4%) | 0.79 |
| Past SBP | 12 (34.3%) | 15 (42.9%) | 0.46 |
| Hepatic Encephalopathy | 9 (25.7%) | 9 (25.7%) | > 0.9 |
| Variceal Bleed | 13 (37.1%) | 14 (40%) | 0.8 |
| Receiving Betablockers | 18 (51.4%) | 16 (45.7%) | 0.63 |
| Receiving Norfloxacin | 12 (34.3%) | 15 (42.9%) | 0.46 |
| Receiving Rifaximin | 9 (25.7%) | 9 (25.7%) | > 0.9 |
| Hemoglobin (g/dl) | 10.21 (2.05) | 10.25(1.67) | 0.92 |
| Platelet, × 10/L | 72 (21–198) | 82(29–217) | 0.59 |
| TLC | 4.5 (1.5–9.8) | 4.1(1.9–9.9) | 0.33 |
| Neutrophils | 75 (40–82) | 72 (43–82) | .64 |
| Lymphocytes | 29.5 (20–40) | 30.5 (20–40) | > .99 |
| Monocytes | 4 (2–8) | 4 (2–10) | 0.06 |
| Eosinophils | 2 (1–6) | 2 (1–6) | 0.24 |
| Basophils | 1 (0–2) | 1 (1–2) | 0.22 |
| Na (mEq/L) | 138 (129–150) | 138(128–144) | 0.87 |
| Serum creatinine (mg/dl) | 0.88 (0.5–1.34) | 0.8(0.56–1.3) | 0.72 |
| Bilirubin (mg/dl) | 1.7 (0.67–4.76) | 1.7(0.5–3.2) | 0.39 |
| Albumin (g/dl) | 3.1 (2.36–4.7) | 3.14(2.34–3.85) | 0.67 |
| INR | 1.34 (1–2.27) | 1.3(1.1–2) | 0.89 |
| MELD | 12 (6–22) | 13(8–23) | 0.14 |
| CTP | 7 (5–11) | 7 (5–12) | 0.35 |
| Body mass index (kg/m2) | 24.21 (20.57- 34.97) | 24.25 (18.75- 32.44) | 0.69 |
| LSM (kPa) | 56 (15–75) | 60 (22–75) | 0.87 |
| Hand-grip strength (Kg) | 32 (24.5–42.6) | 30 (25.4–45.6) | 0.12 |
| Skeletal muscle index (cm2/m2) | 39.9 (29.5–55.6) | 39.2 (29.2–45.2) | 0.99 |
| Physical Component Summary score | 42.47 (6.43) | 44.26 (6.47) | 0.21 |
| Mental Component Summary score | 41.55 (7.75) | 42.85 (8.47) | 0.70 |
INR, International Normalized Ratio; MELD, Model for End-Stage Liver Disease; CTP, Child–Turcotte–Pugh; LSM, liver stiffness measurement